Oncogenic KIT modulates type I interferon–mediated antitumor immunity in GIST

Type I interferons (IFN) are implicated in tumor immunogenicity and response to systemic therapy, but their interaction with oncogene signaling is not well understood. Here, we studied oncogenic KIT, which drives gastrointestinal stromal tumor (GIST), the most common sarcoma. Using mouse models of G...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancer Immunol Res
Asıl Yazarlar: Liu, Mengyuan, Etherington, Mark S., Hanna, Andrew, Medina, Benjamin D., Vitiello, Gerardo A., Bowler, Timothy G., Param, Nesteene J., Levin, Lillian, Rossi, Ferdinand, DeMatteo, Ronald P.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2021
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8102332/
https://ncbi.nlm.nih.gov/pubmed/33648985
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-20-0692
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller